INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 111 filers reported holding INTERSECT ENT INC in Q2 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $7,000 | – | 571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 224,372 | $6,989,000 | 6.40% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $6,230,000 | 1.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,210,000 | $37,692,000 | 1.70% |
| First Light Asset Management, LLC | 170,197 | $5,302,000 | 1.68% |
| Iguana Healthcare Management, LLC | 180,000 | $5,608,000 | 1.55% |
| EAM Investors, LLC | 164,267 | $5,117,000 | 0.68% |
| HAMILTON LANE ADVISORS LLC | 31,560 | $983,000 | 0.68% |
| Rock Springs Capital Management LP | 345,000 | $10,747,000 | 0.50% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 224,482 | $6,992,000 | 0.48% |
| PFM Health Sciences, LP | 768,366 | $23,935,000 | 0.47% |